Generic Medicine OKd by Europe for Thrombocytopenia With HCV - Medscape

Generic Medicine OKd by Europe for Thrombocytopenia With HCV  Medscape

Type Analysis - Market.us

Type Analysis  Market.us

Novartis' Revolade gets expanded coverage for immune thrombocytopenia patients - koreabiomed.com

Novartis' Revolade gets expanded coverage for immune thrombocytopenia patients  koreabiomed.com

Sino Bio's Revolade Generic Approved in China - NAVLIN DAILY

Sino Bio's Revolade Generic Approved in China  NAVLIN DAILY

Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia - The New England Journal of Med...

Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia  The New England Journal of Medicine

Eltrombopag (Revolade): reports of interference with bilirubin and creatinine test results - GOV.UK

Eltrombopag (Revolade): reports of interference with bilirubin and creatinine test results  GOV.UK

GSK's Promacta/Revolade granted breakthrough therapy designation by FDA - Reuters

GSK's Promacta/Revolade granted breakthrough therapy designation by FDA  Reuters

GSK announces the start of a phase III study with eltrombopag in patients with myelodysplastic sy...

GSK announces the start of a phase III study with eltrombopag in patients with myelodysplastic syndromes  GSK

NICE thumbs-up for Revolade - Pharmafile

NICE thumbs-up for Revolade  Pharmafile

Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a pha...

Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study  ScienceDirect.com

New hope for ITP patients dashed by high drug cost - CBC

New hope for ITP patients dashed by high drug cost  CBC

Treatment of immune thrombocytopenia during pregnancy with thrombopoietin receptor agonists - Wil...

Treatment of immune thrombocytopenia during pregnancy with thrombopoietin receptor agonists  Wiley Online Library

Novartis: Blood Disease Drugs Jakavi, Revolade Show Positive Study Results - finchannel

Novartis: Blood Disease Drugs Jakavi, Revolade Show Positive Study Results  finchannel

The Changing Market Dynamics of Immune Thrombocytopenia, Aplastic Anemia, and Diamond-Blackfan An...

The Changing Market Dynamics of Immune Thrombocytopenia, Aplastic Anemia, and Diamond-Blackfan Anemia | DelveInsight Insights  PR Newswire

Merck vaccine, Daiichi ADC win approval recommendations in busy week at EU's drug regulator - Fie...

Merck vaccine, Daiichi ADC win approval recommendations in busy week at EU's drug regulator  Fierce Pharma

Promacta receives Breakthrough Therapy designation for SAA - European Pharmaceutical Review

Promacta receives Breakthrough Therapy designation for SAA  European Pharmaceutical Review

Novartis’ Revolade proved effective for seniors - koreabiomed.com

Novartis’ Revolade proved effective for seniors  koreabiomed.com

GSK guilty of off-label promotion - Pharmafile

GSK guilty of off-label promotion  Pharmafile

Health ministry to reimburse Novartis’ Revolade treating severe aplastic anemia - koreabiomed.com

Health ministry to reimburse Novartis’ Revolade treating severe aplastic anemia  koreabiomed.com

GSK’s Promacta extends US licence - Pharmafile

GSK’s Promacta extends US licence  Pharmafile

Novartis' patent on eltrombopag olamine upheld by Delhi High Court - The Pharma Letter

Novartis' patent on eltrombopag olamine upheld by Delhi High Court  The Pharma Letter

Pill Offers Hope for Hepatitis C Virus Carriers - Duke Global Health Institute

Pill Offers Hope for Hepatitis C Virus Carriers  Duke Global Health Institute

Sobi set to spend up to $915m to acquire Dova Pharmaceuticals - PMLiVE

Sobi set to spend up to $915m to acquire Dova Pharmaceuticals  PMLiVE

How Novartis’s Promacta, Votrient, and Jakavi Performed in 1H17 - Market Realist

How Novartis’s Promacta, Votrient, and Jakavi Performed in 1H17  Market Realist

Coste de eltrombopag y rituximab por paciente respondedor al tratamiento de la trombocitopenia in...

Coste de eltrombopag y rituximab por paciente respondedor al tratamiento de la trombocitopenia inmune primaria en España  SciELO España

Govt to fund drug for rare blood disorder - NZ Herald

Govt to fund drug for rare blood disorder  NZ Herald

Fake cancer drugs sale racket busted in Delhi - The New Indian Express

Fake cancer drugs sale racket busted in Delhi  The New Indian Express

Drug Patents and their Evergreening Conundrum - Bar and Bench

Drug Patents and their Evergreening Conundrum  Bar and Bench